NET PROFIT (x1000 EUR)
Pharmadan A/S
Closing information (x1000 EUR)
| Closing information | 2022/06 | 2021/06 | 2020/06 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-474
|
-433
|
-278 |
| Total assets |
361
|
419
|
446 |
| Current assets |
255
|
286
|
271 |
| Current liabilities |
932
|
620
|
309 |
| Equity capital |
-571
|
-201
|
136 |
| - share capital |
81
|
81
|
81 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2022/06 | 2021/06 | 2020/06 |
| Solvency |
-158.2%
|
-48.0%
|
30.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
27.4%
|
46.1%
|
87.7% |
| Return on equity (ROE) |
83.0%
|
215.4%
|
-204.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/06 | 2021/06 | 2020/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.